Trial
NCT05400746
A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Oxford
Collaborators
—
Condition
Malaria
Intervention
Pfs48/45 in Matrix-M
Why stopped
Significant delays in vaccine adjuvant supply due to an out of specification within the context of the grant timeline. Limited safety and immunological data could be accrued from incomplete regimens.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-28